Why the Wegovy Dose Schedule Starts at 0.25mg
Understanding Your Wegovy Dose Schedule: The Critical 0.25mg Starting Phase
The Wegovy dose schedule begins with a mandatory 0.25mg starter dose for weeks 1-4, and this isn't arbitrary — it's based on extensive clinical research showing that gradual dose escalation significantly reduces side effects whilst maintaining effectiveness. Your body needs time to adjust to semaglutide, the active ingredient that mimics your natural GLP-1 hormone and signals satiety to your brain. Starting with the full 2.4mg maintenance dose would likely cause severe nausea, vomiting, and potentially dangerous dehydration. The carefully designed Wegovy dose schedule protects you whilst building therapeutic levels in your system.
During your first month on the 0.25mg starter dose, you may notice subtle appetite changes — perhaps feeling full after smaller portions or experiencing fewer food cravings between meals. Some patients report mild nausea, particularly in the first few days after each weekly injection, but this typically diminishes as your body adapts. The Wegovy dose schedule is specifically structured so that each dose level prepares your system for the next escalation, creating a foundation for long-term success.
Wegovy Dose Schedule Pricing: Starter Options and Bundle Value
Our 0.25mg Wegovy starter dose costs £79.99 for new customers using discount code FIRST40 at checkout, providing you with 4 weeks of treatment to begin your weight management journey. For those planning ahead, our Intro Duo bundle combines the 0.25mg starter dose with the 0.5mg second-phase dose for £169.99, covering your first 8 weeks of the Wegovy dose schedule with convenient single-order delivery. Returning customers can access the same competitive pricing using discount code DOSE25. These prices reflect our commitment to making clinically-proven weight management accessible whilst maintaining the highest pharmaceutical standards.
The Intro Trio bundle takes forward planning further, including 0.25mg, 0.5mg, and 1mg doses for £299.99 — covering your first 12 weeks of the Wegovy dose schedule. This option is particularly popular with patients who want to ensure continuous supply without multiple prescription reviews. All our Wegovy pricing includes the prescription-only medicine, clinical assessment, prescriber review, and next-day cold-chain delivery to maintain the medication's integrity.
Clinical Evidence Supporting the Wegovy Dose Schedule Protocol
The Wegovy dose schedule used today is based on the landmark STEP clinical trials, particularly STEP 1 where participants following the exact escalation protocol achieved an average weight loss of approximately 15% at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). This research demonstrated that patients who adhered to the complete dose escalation schedule experienced better outcomes than those who attempted to rush or skip doses. The 0.25mg starter dose may seem low, but clinical data shows it's essential for building tolerance whilst initiating the medication's appetite-suppressing effects.
In the STEP trials, the systematic dose escalation minimised discontinuation rates due to gastrointestinal side effects, with the majority of patients successfully progressing through each phase of the Wegovy dose schedule. The research showed that even at the 0.25mg starter level, patients began experiencing measurable changes in appetite regulation and food intake patterns, setting the foundation for sustained weight management success.
How Wegovy Works from Your Very First 0.25mg Injection
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics glucagon-like peptide-1, a hormone your intestines naturally release when you eat. Even at the 0.25mg starter dose, semaglutide begins binding to GLP-1 receptors in your brain's appetite control centres, specifically the hypothalamus and brainstem areas responsible for hunger and satiety signalling. This mechanism starts working within hours of your first injection, though the full appetite-suppressing effects typically develop over several days to weeks. The medication slows gastric emptying, meaning food remains in your stomach longer, naturally extending feelings of fullness after meals. Additionally, Wegovy influences neural pathways that control food reward and craving responses, which may explain why many patients report reduced interest in high-calorie foods even during the starter dose phase.
Your Wegovy Ordering Process: From Assessment to First Injection
Beginning your Wegovy dose schedule with EverydayMeds starts with our comprehensive 3-minute online clinical assessment, designed to evaluate your suitability for this prescription-only medicine based on NICE guidelines and MHRA licensing criteria. Our qualified prescribers review your medical history, current medications, and weight management goals to ensure Wegovy is appropriate for your individual circumstances. Standard prescriber review takes up to 3 working days, though express 24-hour review is available for urgent cases. Once approved, your 0.25mg starter dose ships via next-day delivery using specialized cold-chain packaging that maintains the required 2-8°C temperature throughout transit. Our GPhC-registered pharmacy (#9012878) ensures every Wegovy pen meets pharmaceutical standards before dispatch.
Storage and Practical Considerations for Your Starter Dose
Your 0.25mg Wegovy pen must be stored in the refrigerator at 2-8°C until first use, after which it can remain at room temperature (below 30°C) for up to 6 weeks — significantly longer than competitor medications like Mounjaro's 21-day limit. The FlexTouch pen design makes self-injection straightforward, with a pre-loaded dose that requires no mixing or measuring. Each pen contains 4 doses, perfect for your month-long starter phase, with dose escalation to 0.5mg scheduled for week 5 as part of the structured Wegovy dose schedule. Never skip doses or attempt to accelerate the schedule, as this increases side effect risk and may compromise your treatment outcomes. Store used pens safely and dispose of them through your local pharmacy's sharps disposal service.
First-Time Wegovy Users: What Makes the Starter Dose Schedule Essential
The 0.25mg starting phase of your Wegovy dose schedule serves as your body's introduction to GLP-1 receptor agonism, allowing your digestive system to adapt gradually to slower gastric emptying and altered appetite signals. First-time users often worry this low dose won't be effective, but clinical data shows that even 0.25mg begins the neurological changes that support long-term weight management success. Your starter month is about biological adaptation rather than dramatic weight loss — think of it as laying the groundwork for the more substantial changes that occur as you progress through higher doses.
Many first-time Wegovy users find the starter dose schedule psychologically reassuring, as the lower risk of side effects allows them to build confidence with the injection process and understand how their body responds to treatment. This initial phase is crucial for establishing the dietary and lifestyle changes that amplify Wegovy's effectiveness, as the medication must be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Begin Your Wegovy Journey Today with Expert Support
Ready to start your Wegovy dose schedule with the essential 0.25mg starter dose? Complete our clinical assessment today and join thousands of patients who've begun their weight management journey with EverydayMeds' expert support. New customers save with discount code FIRST40, while returning patients use DOSE25 at checkout. Our clinical team is available throughout your treatment journey, from starter dose through maintenance, ensuring you have the guidance needed for long-term success. Visit https://everydaymeds.co.uk/products/wegovy-0-25mg to begin your assessment, or explore our Intro Duo bundle for comprehensive first-phase coverage. Start safely, start effectively, start with EverydayMeds — your trusted GPhC-registered partner for prescription weight management solutions.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
